Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-03-06 @ 1:13 PM
Study NCT ID:
NCT02115594
Status:
WITHDRAWN
Last Update Posted:
2014-10-08
First Post:
2014-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer
Sponsor:
Syndax Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | metastatic breast cancer | View |
| None | estrogen receptor | View |
| None | Histone Deacetylase Inhibitors | View |
| None | Histone Deacetylases | View |
| None | HDAC inhibitors | View |
| None | selective estrogen receptor modulator | View |
| None | estrogen receptor modulator, selective | View |
| None | Estrogen receptor modulators, selective | View |